Monovisc 4 ml – Single-Dose Knee Pain Injection

Monovisc 4 ml Injection

Description:

Monovisc is a single-dose, high-molecular-weight hyaluronic acid (HA) injection, specifically designed to provide relief from osteoarthritis pain. It is used primarily for the management of knee osteoarthritis in patients who have not responded to conventional pain relief treatments such as nonsteroidal anti-inflammatory drugs (NSAIDs) or other conservative therapies. Monovisc is delivered as a single 4 ml injection directly into the knee joint, aiming to restore lubrication and reduce inflammation in the affected joint. It offers a simple, minimally invasive solution that may help improve joint mobility and function for several months. For details guideline, follow the page.

Composition and Mechanism of Monovisc (1 x 4 ml)

• Composition: Each 4 ml syringe contains 22 mg/ml of hyaluronan derived from bacterial fermentation, ensuring high purity and biocompatibility.
• Mechanism: Hyaluronan supplements the depleted synovial fluid in the joint, restoring its natural viscosity and elasticity. This improves joint lubrication, reduces friction, and minimizes pain and stiffness, enhancing mobility.

Uses:

Monovisc is primarily used to treat knee osteoarthritis, a condition where the cartilage in the knee joint deteriorates, leading to pain, stiffness, and reduced mobility. It is recommended for patients who:

• Have not found adequate relief from over-the-counter medications or NSAIDs.
• Are seeking a non-surgical treatment option for joint pain.
• Prefer a one-time injection over multiple injections or daily oral medications.
• Have moderate to severe knee osteoarthritis.

Directions for Using Monovisc (1 x 4 ml):

Administered via intra-articular injection, Monovisc should be used under the supervision of a healthcare professional. The single-use syringe is ready for application, reducing preparation time. It is typically administered as a one-time injection, with effects lasting up to six months, depending on individual response and activity level.

Potential Side Effects:

Though Monovisc is generally well tolerated, there are potential side effects, which may include:

• Pain at the injection site: This is common and usually resolves within a few days.
• Swelling: Mild swelling in the knee joint may occur following the injection.
• Infection: As with any injection, there is a slight risk of infection at the injection site.
• Allergic Reactions: Rare, but some patients may experience redness, itching, or a rash.
• Joint stiffness: Some users report feeling temporary joint stiffness after the injection.

Managing Side Effects When Using Monovisc:

• Pain and Swelling: Mild pain or swelling can often be managed with over-the-counter pain relievers, such as acetaminophen, as advised by your healthcare provider. Cold compresses applied to the area may also help reduce swelling.
• Infection Prevention: To minimize the risk of infection, it’s important to follow proper aftercare instructions provided by your healthcare provider, including keeping the injection site clean and avoiding pressure or irritation in the days following the injection.
• Stiffness or Discomfort: Gentle movement of the knee can help alleviate stiffness. Avoid high-impact activities for a few days post-injection.
• Allergic Reactions: If you notice signs of a more severe allergic reaction, such as difficulty breathing, swelling in the face or throat, or severe skin rash, seek immediate medical attention.

It is important to discuss any concerns with your healthcare provider prior to receiving the injection, especially if you have any history of allergies or joint infections. If side effects persist or worsen, consult your doctor for further advice.

This detailed description provides essential information on Monovisc (1 x 4 ml), its uses, composition, and side effects to ensure proper understanding and usage for patients.